| Zanganeh Mahkam |
Chief Executive Officer |
Summit Therapeutics Inc. (SMMT)
|
2024-03-27 |
$3.73 |
235.4% |
110,321
|
$411,094 |
| Zanganeh Mahkam |
Chief Executive Officer |
Summit Therapeutics Inc. (SMMT)
|
2023-12-12 |
$2.07 |
503.9% |
5,000
|
$10,350 |
| Zanganeh Mahkam |
Co-Chief Executive Officer |
Summit Therapeutics Inc. (SMMT)
|
2023-03-08 |
$1.05 |
1090.5% |
23,527,044
|
$24,703,396 |
| Zanganeh Maky |
Co |
Summit Therapeutics Inc. (SMMT)
|
2022-08-16 |
$0.97 |
1188.7% |
5,809,132
|
$5,634,858 |
| Zanganeh Maky |
Chief Operating Officer |
Summit Therapeutics Inc. (SMMT)
|
2021-05-12 |
$5.24 |
138.5% |
389,077
|
$2,038,763 |
| Zanganeh Maky |
Non-Executive Director |
Pulse Biosciences, Inc. (PLSE)
|
2020-06-23 |
$10.70 |
63.3% |
1,193
|
$12,767 |
| Zanganeh Maky |
Non-Executive Director |
Pulse Biosciences, Inc. (PLSE)
|
2020-06-17 |
$7.01 |
149.4% |
7,950
|
$55,730 |
|
|
|
|
|
Return |
Profit / (loss) |
Cost |
|
|
|
Total |
|
1035.4% |
$340,300,036 |
$32,866,958 |